CD4 and non-small cell lung carcinoma: A higher anti-TERT Th1 response and low expression of PD-1+ T cell immunoglobulin (Ig) mucin-3 (TIM-3)+ CD4+ T exhausted cells are associated with better patient prognosis in non-small cell lung cancer (NSCLC).